20160128 EGA Regulatory and Scientific Affairs Conferenc

Opinion piece by Christoph Stoller for Friends of Europe

3 June 2021

“Too much at stake in the EU pharma strategy to […]

Read more

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

Read More

EU Industrial strategy should be key to improving medicines supply chains

17 May 2021

The newly launched update of the industrial strategy aims to […]

Read more

“Off patent medicines essential for a fairer, healthier, and sustainable Europe” says President Christoph Stoller

30 April 2021

Christoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]

Read more

EU Industry Welcomes New Schengen Strategy’s Green Lanes

7 April 2021


EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

17 March 2021

Read More

New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability

1 March 2021

Read More

Smart policies will encourage more critical medicines manufacturing in Europe

26 February 2021

Read More

A new medicines trade and health security agenda for the European Commission

19 February 2021

In response to the European Commission Trade Communication published on […]

Read more

No further excuse to delay digital regulatory infrastructure for medicines after Covid-19 pandemic

19 February 2021

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]